Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren’s Syndrome
Condition(s):Sjogren SyndromeLast Updated:March 22, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Sjogren SyndromeLast Updated:March 22, 2024Recruiting
Condition(s):Sjogren’s Syndrome Childhood-onsetLast Updated:April 19, 2021Active, not recruiting
Condition(s):Primary Sjögren’s SyndromeLast Updated:September 8, 2021Unknown status
Condition(s):Sjogren’s Syndrome; Sjögren; Sjögren Syndrome, UnspecifiedLast Updated:March 7, 2024Not yet recruiting
Condition(s):Sjogren SyndromeLast Updated:March 26, 2024Recruiting
Condition(s):Sjögren’s SyndromeLast Updated:May 6, 2019Unknown status
Condition(s):Dry Eye; Sjogren SyndromeLast Updated:May 22, 2019Completed
Condition(s):Sjögren’s SyndromeLast Updated:March 13, 2024Recruiting
Condition(s):Sjogren’s SyndromeLast Updated:May 25, 2022Not yet recruiting
Condition(s):Primary Sjögren’s SyndromeLast Updated:March 4, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.